Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of antimicrobial photodynamic therapy in chronic leg ulcers and diabetic foot ulcers
2005-001363-58Phase 2Completed
- Sponsor
- Photopharmica
- Start
- Mar 2005
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in leg ulcer and diabetic foot ulcer (DFU) comparing PPA904 antimicrobial photodynamic therapy with Placebo photodynamic therapy (2 arms). Primary endpoint: Bacterial load reduction in ulcers. Started Mar 2005; status: completed.
02
Drugs
PPA-904
03
Conditions
leg ulcerdiabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2005-001363-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001363-58.